Extension to Indications for Use follows submission of results from a human factors study evaluating the safe and effective use of the device in the home care setting.

The company that brought you no-stick toothpaste is moving into the medical space, with a lubricant for ostomy pouches and other products that could improve millions of lives.

A mathematical method, validated with experimental data, provides a fast, reliable, and minimally invasive way of determining how to treat critical blood pressure changes during surgery or intensive care.

Corify Care announced today that it received CE mark approval under the new medical device regulation (MDR) for its Acorys cardiac mapping system.

CorVascular announced today that the FDA granted clearance for its VasoGuard V-Series portfolio of devices.

EYSINS, Switzerland, July 29, 2024 /PRNewswire/ — AliveDx (“Company”) is proud to announce it has received IVDR CE mark for its groundbreaking microarray immunoassay, designed for the detection of a specific IgE directed to a protein allergen in human serum. This is the Company’s first product for the evaluation of allergies, enhancing its portfolio of products beyond autoimmunity.

In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.

A researcher at AIST, in collaboration with the Japan Medical Startup Incubation Program (JMPR) and N.B. Medical Corporation, has developed a novel anti-thrombogenic coating for stents used in the treatment of intracranial aneurysms. The details of this technology were published in Scientific Reports on July 10, 2024.